Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) Net Margin (2024 - 2025)

Beta Bionics (BBNX) has disclosed Net Margin for 2 consecutive years, with 41.92% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 1721.0% to 41.92% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 60.6% through Dec 2025, up 289.0% year-over-year, with the annual reading at 60.6% for FY2025, 289.0% up from the prior year.
  • Net Margin hit 41.92% in Q4 2025 for Beta Bionics, up from 52.14% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 41.92% in Q4 2025 to a low of 91.88% in Q1 2025.